malondialdehyde has been researched along with irl 1620 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briyal, S; Gulati, A; Leonard, MG | 2 |
2 other study(ies) available for malondialdehyde and irl 1620
| Article | Year |
|---|---|
Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats.
Topics: Analysis of Variance; Animals; Brain Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin B Receptor Antagonists; Endothelins; Gene Expression Regulation; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Motor Activity; Muscle Strength; Nervous System Diseases; Neurologic Examination; Oligopeptides; Peptide Fragments; Piperidines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Rotarod Performance Test; Superoxide Dismutase | 2011 |
Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats.
Topics: Animals; Brain; Brain Ischemia; Endothelins; Glutathione; Malondialdehyde; Motor Activity; Muscle Strength; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Rats; Receptor, Endothelin B; Superoxide Dismutase; Up-Regulation | 2012 |